DEAL ANNOUNCEMENT / PRESS RELEASE
May 10, 2026
Read time: 3 min
McDermott Will & Schulte advised Generare, a biotechnology company that generates innovative, high-quality molecular data for drug development, on a €20 million Series A fundraising round co-led by Alven and daphni, with participation from existing investors Teampact.ventures, Galion.exe, and VIVES Partners.
This financing will enable Generare to increase its platform’s capacity tenfold, collaborate with leading partners in drug discovery and crop protection, and condense into a few years what has taken a century of exploration and discovery.
The McDermott Will & Schulte team involved in the transaction consisted of:
- Anthony Paronneau, partner
- Natacha Vasak, associate
- Camille Pasquereau, associate
- Pauline Orliange, associate
Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.
